What is the primary purpose of the intraocular contact lens called IPCL®?

The primary purpose of IPCL® is to correct myopia and astigmatism by inserting a small lens into the eye.

What material is IPCL® made from, and where else is this material commonly used?

IPCL® is made from an acrylic polymer material with HEMA as the main component, which is widely used in intraocular lenses for cataracts and contact lenses.

How does IPCL® differ from LASIK in terms of corneal treatment?

Unlike LASIK, IPCL® does not ablate the cornea, making it a highly reversible treatment method that allows for future lens removal.

When did IPCL® receive pharmaceutical approval from the Ministry of Health, Labour and Welfare in Japan, and when was it launched?

IPCL® obtained pharmaceutical approval from the Ministry of Health, Labour and Welfare in April 2025 and was launched in September of the same year.

What was the main objective of the survey conducted by Working Inc. regarding intraocular contact lenses?

The main objective of the survey was to clarify the awareness and understanding of intraocular contact lenses among men and women aged 20-40 with vision below 0.1.

AI News NQ Analysis

Survey on Awareness of Intraocular Lenses (Phakic Posterior Chamber Lenses) for Men and Women Aged 20-40 with Vision Below 0.1

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the primary purpose of the intraocular contact lens called IPCL®?: A: The primary purpose of IPCL® is to correct myopia and astigmatism by inserting a small lens into the eye.
Q: What material is IPCL® made from, and where else is this material commonly used?: A: IPCL® is made from an acrylic polymer material with HEMA as the main component, which is widely used in intraocular lenses for cataracts and contact lenses.
Q: How does IPCL® differ from LASIK in terms of corneal treatment?: A: Unlike LASIK, IPCL® does not ablate the cornea, making it a highly reversible treatment method that allows for future lens removal.
Q: When did IPCL® receive pharmaceutical approval from the Ministry of Health, Labour and Welfare in Japan, and when was it launched?: A: IPCL® obtained pharmaceutical approval from the Ministry of Health, Labour and Welfare in April 2025 and was launched in September of the same year.
Q: What was the main objective of the survey conducted by Working Inc. regarding intraocular contact lenses?: A: The main objective of the survey was to clarify the awareness and understanding of intraocular contact lenses among men and women aged 20-40 with vision below 0.1.